Hajime Sakai
Fondatore presso Napigen, Inc.
Patrimonio netto: 509 111 $ in data 30/04/2024
Profilo
Hajime Sakai has founded Napigen, Inc. in 2016 and currently holds the titles of President, Chief Executive Officer & Director.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
SHINTO PAINT CO., LTD.
1.07% | 30/09/2023 | 332 000 ( 1.07% ) | 270 049 $ | 30/04/2024 |
TOWNNEWS-SHA CO., LTD.
0.89% | 30/06/2023 | 49 500 ( 0.89% ) | 239 062 $ | 30/04/2024 |
Posizioni attive di Hajime Sakai
Società | Posizione | Inizio |
---|---|---|
Napigen, Inc.
Napigen, Inc. Agricultural Commodities/MillingProcess Industries Napigen, Inc. is a biotechnology company that specializes in genome engineering of various organisms such as plants, microbes, and animals. The company is based in Wilmington, DE and Dr. Hajime Sakai has been the CEO since 2016. The company's technology targets mitochondria and chloroplasts, which are important for creating energy and producing biochemical molecules. The company's genome technology has broad applications in human and animal healthcare, agriculture, and industrial biotechnology. Napigen was founded in 2016 by a group of accomplished scientists, entrepreneurs, and investors including Dr. Hajime Sakai, Dr. Jay Keasling, Dr. Ganesh Kishore, and Dr. Roger Wyse. | Fondatore | 01/01/2016 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Napigen, Inc.
Napigen, Inc. Agricultural Commodities/MillingProcess Industries Napigen, Inc. is a biotechnology company that specializes in genome engineering of various organisms such as plants, microbes, and animals. The company is based in Wilmington, DE and Dr. Hajime Sakai has been the CEO since 2016. The company's technology targets mitochondria and chloroplasts, which are important for creating energy and producing biochemical molecules. The company's genome technology has broad applications in human and animal healthcare, agriculture, and industrial biotechnology. Napigen was founded in 2016 by a group of accomplished scientists, entrepreneurs, and investors including Dr. Hajime Sakai, Dr. Jay Keasling, Dr. Ganesh Kishore, and Dr. Roger Wyse. | Process Industries |
- Borsa valori
- Insiders
- Hajime Sakai